Biosimilars
Curaxys: the biopharmaceuticals company focused on production of biosimilars medicines.
We specialize in creating original technologies to develop new biological process useful for the production of therapeutical biological compounds: BIOSIMILARS.
The biological process used are the result of an exclusive technological partnership with universities, research institutions and biotechnological companies and CMO.
The technologies applied are based on microbial fermentation, mammalian cell culture, insect cell culture using a Baculovirus Expression Vector System (BEVS) Protocol for the production of recombinant proteins and transgenic plant. The technologies allows to us to produce therapeutical proteins of great interest as biosimilars are.
